Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for hard-to-treat myeloma patients?

NCT ID NCT02626481

Completed Disease control Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a drug called daratumumab combined with dexamethasone in 64 people with multiple myeloma that had stopped responding to three other treatments. The goal was to see how many patients' tumors shrank or disappeared. The treatment is not a cure, but aims to control the disease for as long as possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE MYELOMA

Contacts and locations

Locations

  • AZ ST Jan hematology department

    Bruges, 8000, Belgium

  • CHRU , Hôpital Claude Huriez

    Lille, France

  • CHRU - Hôpital du Bocage (Amiens)

    Amiens, 49033, France

  • CHRU Côte de Nacre

    Caen, 14033, France

  • CHRU, Hôpital A.Michallon

    Grenoble, 38043, France

  • CHRU-Hôpital Sud d'Amiens

    Amiens, 80054, France

  • CHU - Hôpital St Antoine

    Paris, 75571, France

  • CHU Dinant Godinne | UCL Namur asbl

    Yvoir, 1 - 5530, Belgium

  • CHU de la milétrie

    Poitiers, 86000, France

  • Centre Hospitalier Général

    Dunkirk, 59 385, France

  • Centre Hospitalier Lyon sud

    Pierre-Bénite, 69495, France

  • Centre Hospitalier William Morey

    Chalon-sur-Saône, 71100, France

  • Clinique - ICH CHU de Brest Hôpital Morvan

    Brest, 29609, France

  • Curie Institut

    Paris, 75248, France

  • Département d'Hématologie et Oncologie Hôpitaux Universitaires de Strasbourg

    Strasbourg, 67091, France

  • Hematologie Laarbeeklaan

    Brussels, 101 - 1090, Belgium

  • Hopital E Muller

    Mulhouse, 68100, France

  • Hopital J Monod Sce Rhumato Nord

    Montivilliers, 76290, France

  • Hématologie CHRU IUCT Oncopole

    Toulouse, 31100, France

  • Hématologie Clinique CHU DIJON

    Dijon, 21000, France

  • Hôpital Avicenne

    Bobigny, 93009, France

  • Hôpital R.Debré

    Reims, 51032, France

  • Hôpital Saint-Louis

    Paris, 75475, France

  • Hôpital d'instruction des armées Percy

    Clamart, 92141, France

  • Hôpital de Pontchaillou

    Rennes, 35033, France

  • Hôpital du Haut Lévêque Centre François Magendie

    Bordeaux, 33604, France

  • Hôpitaux de Brabois

    Vandœuvre-lès-Nancy, 54511, France

  • Institut Paoli Calmette

    Marseille, 13273, France

  • Jules Bordet Institute

    Brussels, B - 1000, Belgium

  • Maladies du sang CHRU Hôtel Dieu

    Nantes, 44035, France

  • Médecine interne Centre hospitalier départemental

    La Roche-sur-Yon, 85025, France

  • Onco-hématologie CHRU Hôpital Bretonneau

    Tours, 37044, France

  • Polyclinique Bordeaux Nord Aquitaine

    Bordeaux, 33300, France

  • Sce Hématologie Thérapie Cellulaire CHU Limoges

    Limoges, 87000, France

  • Service Hématologie CHRU Montpellier

    Montpellier, 34090, France

  • Service Hématologie Centre Hospitalier Yves le Foll

    Saint-Brieuc, 22000, France

  • Service d'Hématologie CHV André Mignot

    Le Chesnay, 78157, France

  • Service d'Hématologie Clinique Institut de Cancérologie Lucien Neuwirth

    Saint-Priest-en-Jarez, 42270, France

  • URC/CIC Paris Descartes Necker-Cochin

    Paris, 75015, France

  • Unité de Recherche Clinique - CH Périgueux

    Périgueux, 24019, France

  • service hématologie CH Bretagne Atlantique

    Vannes, 56017, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.